These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9770376)

  • 1. Agonist and antagonist-dependent internalization of the human vasopressin V2 receptor.
    Pfeiffer R; Kirsch J; Fahrenholz F
    Exp Cell Res; 1998 Oct; 244(1):327-39. PubMed ID: 9770376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of agonist-dependent parathyroid hormone receptor trafficking in whole cells using a functional green fluorescent protein conjugate.
    Conway BR; Minor LK; Xu JZ; D'Andrea MR; Ghosh RN; Demarest KT
    J Cell Physiol; 2001 Dec; 189(3):341-55. PubMed ID: 11748592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function.
    Zhu X; Wess J
    Biochemistry; 1998 Nov; 37(45):15773-84. PubMed ID: 9843382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescent pseudo-peptide linear vasopressin antagonists: design, synthesis, and applications.
    Durroux T; Peter M; Turcatti G; Chollet A; Balestre MN; Barberis C; Seyer R
    J Med Chem; 1999 Apr; 42(7):1312-9. PubMed ID: 10197974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication.
    Schöneberg T; Sandig V; Wess J; Gudermann T; Schultz G
    J Clin Invest; 1997 Sep; 100(6):1547-56. PubMed ID: 9294123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats.
    Yamamura Y; Nakamura S; Itoh S; Hirano T; Onogawa T; Yamashita T; Yamada Y; Tsujimae K; Aoyama M; Kotosai K; Ogawa H; Yamashita H; Kondo K; Tominaga M; Tsujimoto G; Mori T
    J Pharmacol Exp Ther; 1998 Dec; 287(3):860-7. PubMed ID: 9864265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine H2 receptor trafficking: role of arrestin, dynamin, and clathrin in histamine H2 receptor internalization.
    Fernandez N; Monczor F; Baldi A; Davio C; Shayo C
    Mol Pharmacol; 2008 Oct; 74(4):1109-18. PubMed ID: 18617631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
    Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
    J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells.
    Pheng LH; Dumont Y; Fournier A; Chabot JG; Beaudet A; Quirion R
    Br J Pharmacol; 2003 Jun; 139(4):695-704. PubMed ID: 12812992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modelling of the vasopressin V2 receptor/antagonist interactions.
    Czaplewski C; Kaźmierkiewicz R; Ciarkowski J
    Acta Biochim Pol; 1998; 45(1):19-26. PubMed ID: 9701492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.
    Kaufmann JE; Oksche A; Wollheim CB; Günther G; Rosenthal W; Vischer UM
    J Clin Invest; 2000 Jul; 106(1):107-16. PubMed ID: 10880054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach.
    Oshikawa S; Tanoue A; Koshimizu TA; Kitagawa Y; Tsujimoto G
    Mol Pharmacol; 2004 Mar; 65(3):623-9. PubMed ID: 14978240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of a selective vasopressin V1A receptor antagonist SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed.
    Heinemann A; Horina G; Stauber RE; Pertl C; Holzer P; Peskar BA
    Br J Pharmacol; 1998 Nov; 125(6):1120-7. PubMed ID: 9863637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes.
    Nakamura S; Yamamura Y; Itoh S; Hirano T; Tsujimae K; Aoyama M; Kondo K; Ogawa H; Shinohara T; Kan K; Tanada Y; Teramoto S; Sumida T; Nakayama S; Sekiguchi K; Kambe T; Tsujimoto G; Mori T; Tominaga M
    Br J Pharmacol; 2000 Apr; 129(8):1700-6. PubMed ID: 10780976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internalization and trafficking of the human and rat growth hormone-releasing hormone receptor.
    Veyrat-Durebex C; Pomerleau L; Langlois D; Gaudreau P
    J Cell Physiol; 2005 May; 203(2):335-44. PubMed ID: 15499571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities.
    Morin D; Cotte N; Balestre MN; Mouillac B; Manning M; Breton C; Barberis C
    FEBS Lett; 1998 Dec; 441(3):470-5. PubMed ID: 9891993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrestin effects on internalization of vasopressin receptors.
    Bowen-Pidgeon D; Innamorati G; Sadeghi HM; Birnbaumer M
    Mol Pharmacol; 2001 Jun; 59(6):1395-401. PubMed ID: 11353798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning and functional characterization of V2 [8-lysine] vasopressin and oxytocin receptors from a pig kidney cell line.
    Gorbulev V; Büchner H; Akhundova A; Fahrenholz F
    Eur J Biochem; 1993 Jul; 215(1):1-7. PubMed ID: 8393786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of the human arginine vasopressin V2 receptor after site-directed mutagenesis of its putative palmitoylation site.
    Schülein R; Liebenhoff U; Müller H; Birnbaumer M; Rosenthal W
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):611-6. PubMed ID: 8573100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisit ligand-receptor interaction at the human vasopressin V
    Liu C; Xia L; Fu K; Cao X; Yan W; Cheng J; Roux T; Peletier LA; Yin X; Guo D
    Eur J Pharmacol; 2020 Aug; 880():173157. PubMed ID: 32360346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.